Liver and biliary tract disorders.
Richard H
RH
Moseley
D000998:Antiviral Agents / Q000627:therapeutic use; D001660:Biliary Tract Diseases / Q000150:complications / Q000209:etiology* / Q000628:therapy*; D064420:Drug-Related Side Effects and Adverse Reactions; D020022:Genetic Predisposition to Disease; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D006801:Humans; D008107:Liver Diseases / Q000150:complications / Q000209:etiology* / Q000628:therapy*; D008565:Membrane Proteins; D008517:Phytotherapy / Q000009:adverse effects
D000998:Antiviral Agents; C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins